Information
-
Trademark
-
79372184
-
Serial Number
79372184
-
Registration Number
7525664
-
International Classifications
-
Filing Date
April 13, 2023
a year ago
-
Registration Date
October 08, 2024
3 months ago
-
Transaction Date
January 08, 2025
14 days ago
-
Status Date
October 08, 2024
3 months ago
-
Published for Opposition Date
July 23, 2024
6 months ago
-
Location Date
October 07, 2024
3 months ago
-
Status Code
700
-
Current Location
FILE REPOSITORY (FRANCONIA)
Employee Name
EISNACH, MICHAEL
-
Attorney Docket Number
BYL0191TUS
Attorney Name
Michelle P. Ciotola
-
Owners
Mark Drawing Code
4
Mark Identification
TAZOVID
Case File Statements
- GS0051: Medicines for human purposes for the treatment of insomnia, amnesia, asthenia, neurasthenia, chronic chest diseases, chronic tracheitis and bronchitis, coronary thrombosis, fever, influenza, vertigo, hyperlipidemia, adiposity, obesity and COVID-19; Pharmaceutical preparations for the treatment of insomnia, amnesia, asthenia, neurasthenia, chronic chest diseases, chronic tracheitis and bronchitis, coronary thrombosis, fever, influenza, vertigo, hyperlipidemia, adiposity, obesity and COVID-19; Capsules being medicines for the treatment of insomnia, amnesia, asthenia, neurasthenia, chronic chest diseases, chronic tracheitis and bronchitis, coronary thrombosis, fever, influenza, vertigo, hyperlipidemia, adiposity, obesity and COVID-19; Drugs for medical purposes for the treatment of insomnia, amnesia, asthenia, neurasthenia, chronic chest diseases, chronic tracheitis and bronchitis, coronary thrombosis, fever, influenza, vertigo, hyperlipidemia, adiposity, obesity and COVID-19; vaccines; Ointments for pharmaceutical purposes for the treatment of skin conditions; Medicines in the form of tablets for the treatment of insomnia, amnesia, asthenia, neurasthenia, chronic chest diseases, chronic tracheitis and bronchitis, coronary thrombosis, fever, influenza, vertigo, hyperlipidemia, adiposity, obesity and COVID-19; biocides; Dietetic preparations adapted for medical purposes; Depuratives for the body; Medicines for veterinary purposes for the treatment of COVID-19; dental lacquer
Case File Event Statements
-
6/27/2023 - a year ago
3 - APPLICATION FILING RECEIPT MAILED
Type: MAFR
-
6/22/2023 - a year ago
1 - SN ASSIGNED FOR SECT 66A APPL FROM IB
Type: REPR
-
6/23/2023 - a year ago
2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Type: NWOS
-
1/10/2024 - a year ago
4 - ASSIGNED TO EXAMINER
Type: DOCK
-
6/13/2024 - 7 months ago
11 - CORRESPONDENCE RECEIVED IN LAW OFFICE
Type: CRFA
-
1/17/2024 - a year ago
5 - NON-FINAL ACTION WRITTEN
Type: CNRT
-
1/18/2024 - a year ago
6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Type: RFCR
-
2/1/2024 - 11 months ago
7 - REFUSAL PROCESSED BY MPU
Type: RFRR
-
2/1/2024 - 11 months ago
8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Type: RFCS
-
2/19/2024 - 11 months ago
9 - REFUSAL PROCESSED BY IB
Type: RFNT
-
6/13/2024 - 7 months ago
12 - TEAS/EMAIL CORRESPONDENCE ENTERED
Type: TEME
-
6/13/2024 - 7 months ago
10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED
Type: TROA
-
6/14/2024 - 7 months ago
15 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Type: GNEN
-
6/14/2024 - 7 months ago
14 - EXAMINERS AMENDMENT E-MAILED
Type: GNEA
-
6/14/2024 - 7 months ago
13 - EXAMINERS AMENDMENT -WRITTEN
Type: CNEA
-
7/23/2024 - 6 months ago
19 - PUBLISHED FOR OPPOSITION
Type: PUBO
-
6/14/2024 - 7 months ago
17 - APPROVED FOR PUB - PRINCIPAL REGISTER
Type: CNSA
-
6/14/2024 - 7 months ago
16 - EXAMINER'S AMENDMENT ENTERED
Type: XAEC
-
7/3/2024 - 6 months ago
18 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Type: NONP
-
7/23/2024 - 6 months ago
20 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Type: NPUB
-
10/8/2024 - 3 months ago
21 - REGISTERED-PRINCIPAL REGISTER
Type: R.PR
-
10/8/2024 - 3 months ago
22 - NOTICE OF REGISTRATION CONFIRMATION EMAILED
Type: NRCC
-
1/8/2025 - 14 days ago
23 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Type: FICR